1-14 of 14 results for subject:"Gene Therapy Advisory Committee"
Librarians' tools
- Search time
- 0.258 seconds
- Solr query time
- 0.003 seconds
- Search query
- subject:"Gene Therapy Advisory Committee"
- We searched for
- subject_t:"Gene Therapy Advisory Committee" OR subject_t:GTAC OR subject_t:"Lloyd Committee" OR subject_ses:36273
Type
House
Session
Year
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Health what his most recent assessment is of the performance of the Gene Therapy Advisory Committee.
To ask the Secretary of State for Health what his most recent assessment is of the performance of the Gene Therapy Advisory Committee.
To ask the Secretary of State for Health (1) how many full-time equivalent staff are employed by the Gene Therapy Advisory Committee;
To ask the Secretary of State for Health (1) how many full-time equivalent staff are employed by the Gene Therapy Advisory Committee;
(2) what (a) capital, (b) revenue and (c) other funding his Department has given to the Gene Therapy Advisory Committee since its inception.
(2) what (a) capital, (b) revenue and (c) other funding his Department has given to the Gene Therapy Advisory Committee since its inception.
SI 2008/941. (Negative instrument). Together with an explanatory memorandum and impact assessment from the Department of Health. Coming into force 1 May 2008. Amends SI 2004/1031 and SI 2005/50.
SI 2008/941. (Negative instrument). Together with an explanatory memorandum and impact assessment from the Department of Health. Coming into force 1 May 2008. Amends SI 2004/1031 and SI 2005/50.
To ask the Secretary of State for Health, if he will list the (a) date of appointment, (b) terms of reference and (c) membership of the focus groups established by his Department to discuss genetic engineering. - Inc membership of Gene Therapy Advisory Committee and Human Genetics Advisory Commission.
To ask the Secretary of State for Health, if he will list the (a) date of appointment, (b) terms of reference and (c) membership of the focus groups established by his Department to discuss genetic engineering. - Inc membership of Gene Therapy Advisory Committee and Human Genetics Advisory Commission.
Statement on plans to review the work of the Gene Therapy Advisory Committee. - Inc appointments to small team to undertake a review of GTAC's role and functions.
Statement on plans to review the work of the Gene Therapy Advisory Committee. - Inc appointments to small team to undertake a review of GTAC's role and functions.
Statement on what plans he has to review the work of the Gene Therapy Advisory Committee. - Inc appointments to small team to review GTAC role and functions.
Statement on what plans he has to review the work of the Gene Therapy Advisory Committee. - Inc appointments to small team to review GTAC role and functions.
The Human Genome Project, gene therapy and patenting. House of Commons Library Research Paper 97/128.
The Human Genome Project, gene therapy and patenting. House of Commons Library Research Paper 97/128.
Lords debate on motion to call attention to threats posed and benefits offered to humankind by human genetic manipulation and assisted procreation.
Lords debate on motion to call attention to threats posed and benefits offered to humankind by human genetic manipulation and assisted procreation.
Statement about Government control of human gene technology.
Statement about Government control of human gene technology.
If she will set out the terms of reference of the Gene Therapy Advisory Committee.
If she will set out the terms of reference of the Gene Therapy Advisory Committee.
What is the membership of her committee on the ethics of gene therapy; and if she will list each member's current professional position. - Inc fact that Committee on the Ethics of Gene Therapy was disbanded on 19 Nov 1993. It has been replaced by the Gene Therapy Advisory Committee,...
What is the membership of her committee on the ethics of gene therapy; and if she will list each member's current professional position. - Inc fact that Committee on the Ethics of Gene Therapy was disbanded on 19 Nov 1993. It has been replaced by the Gene Therapy Advisory Committee,...
Statement on when she expects to be able to announce the Chairman and terms of reference of the Gene Therapy Advisory Committee. - Inc fact that Prof Dame June Lloyd appointed & details of terms of reference.
Statement on when she expects to be able to announce the Chairman and terms of reference of the Gene Therapy Advisory Committee. - Inc fact that Prof Dame June Lloyd appointed & details of terms of reference.
Statement on the report of the Committee on the Ethics of Gene Therapy. - Inc fact that intend setting up a new body, the gene therapy advisory committee. This will consider proposals to apply gene therapy to patients.
Statement on the report of the Committee on the Ethics of Gene Therapy. - Inc fact that intend setting up a new body, the gene therapy advisory committee. This will consider proposals to apply gene therapy to patients.